UM-164 is primarily used in cancer research, particularly in the study of drug-resistant tumors. It functions as a dual inhibitor of key signaling pathways involved in cell survival and proliferation, making it a valuable tool for investigating mechanisms of apoptosis and tumor suppression. Researchers utilize UM-164 to overcome resistance to conventional chemotherapy by targeting cancer stem cells, which are often responsible for recurrence and metastasis. Its application extends to preclinical studies in breast, lung, and colon cancers, where it has shown potential to enhance the efficacy of existing anticancer agents. Due to its ability to modulate specific tyrosine kinase receptors and downstream effectors, UM-164 supports the development of novel therapeutic strategies aimed at improving treatment outcomes in aggressive and resistant cancers.